SVB Leerink Maintains Outperform on Agios Pharmaceuticals, Raises Price Target to $37
SVB Leerink analyst Andrew Berens maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Outperform and raises the price target from $33 to $37.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
SVB Leerink Upgrades Agios Pharmaceuticals to Outperform, Maintains $33 Price Target
SVB Leerink analyst Andrew Berens upgrades Agios Pharmaceuticals (NASDAQ:AGIO) from Market Perform to Outperform and maintains $33 price target.
The Daily Biotech Pulse: AstraZeneca’s COVID-19 Vaccine As Effective As mRNA Shots, Humanigen’s Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth’s Alzheimer’s Program
Here's a roundup of top developments in the biotech space over the last 24 hours:
Delta Air Lines, Fastenal And 3 Stocks To Watch Heading Into Wednesday
With the US stock futures trading slightly higher this morning on Wednesday after recording losses in the previous session, some of the stocks that may grab investor focus today are as follows:
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Goldman Sachs Maintains Sell on Agios Pharmaceuticals, Lowers Price Target to $16
Goldman Sachs maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sell and lowers the price target from $20 to $16.
Agios Is Looking For Development Partner, Lays Off Exploratory Research Staff
Agios Pharmaceuticals Inc (NASDAQ:AGIO) will be letting go of 50 employees and shuffling its R&D leadership team to focus internal research…